Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (2566.HK)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Hang Fu
|
Executive Chairman & GM | 1.81M | -- | 1963 |
|
Mr. Wei Zhou
|
Deputy GM, GM of Pharmacy Services & Executive Director | 1.74M | -- | 1976 |
|
Ms. Yanmei Yang
|
Financial Controller | -- | -- | 1990 |
|
Mr. Hui Li
|
Deputy GM & Chief Manager of Manufacturing Center | -- | -- | 1973 |
|
Mr. Handong Sun
|
Deputy GM and Chief Manager of the Research & Development center | -- | -- | 1972 |
|
Ms. Xiu Huang
|
Joint Company Secretary | -- | -- | 1978 |
|
Ms. Wing Nga Ho P.E.
|
Joint Company Secretary | -- | -- | 1971 |
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 1,787
Description
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and internationally. The company offers Guyoudao, a bone repair material; Jilifen, a human granulocyte colony stimulating factor injection; Jijufen, a human interleukin-11 injection; Jiouting, a palonosetron hydrochloride injection; Jifuwei, a fulvestrant injection; Jitansu, a fosaprepitant dimeglumine injection; and Jixinfen, PEG-G–CSF injection. It also provides Jilixin avatrombopag maleate tablets; Jipailin, a low molecular weight heparin sodium injection; and Yinuojia, an enoxaparin sodium injection. The company was formerly known as Hangzhou Jiuyuan Gene Engineering Co., Ltd. and changed its name to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. in April 2025. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. was incorporated in 1993 and is headquartered in Hangzhou, China.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
June 17, 2026 at 12:00 AM UTC
Ex-Dividend Date
